Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06237790

A Comparative Analysis of Speech Perception Between Cochlear Implant Patients and DFNB9 Patients Receiving Gene Therapy

Status
Recruiting
Phase
Study type
Observational
Enrollment
180 (estimated)
Sponsor
Eye & ENT Hospital of Fudan University · Academic / Other
Sex
All
Age
6 Months
Healthy volunteers
Accepted

Summary

This cohort study aims to explore the trends and differences in multidimensional perceptual levels of patients after cochlear implants or gene therapy, as well as to comprehensively assess the efficacy of gene therapy for congenital deafness, thus providing a reference for making a well-rounded postoperative rehabilitation protocol for gene therapy patients.

Detailed description

Cochlear implant patients exhibit improved speech perception in quiet environments after surgery, but their music perception and speech perception under noise are still unsatisfactory. Gene therapy is a novel and promising treatment for congenital hearing loss to recover natural hearing sensations. To date, for patients with congenital deafness, there has been no study on their ability to perceive and understand sounds, such as speech perception in noise, music and directional perception, after hearing recovery owing to gene therapy. In addition, the difference between the two treatments in those perceptual levels postoperatively remains unknown. Therefore, the investigators designed a single-center cohort study. Based on the intervention method, congenital deafness patients are divided into two groups: the cochlear implant group and the gene therapy group. In the present study, a full-scale evaluation of the two groups will be conducted. The battery encompasses auditory speech perception, cognition, psychological status, and auditory cortex development. A comparative analysis will be conducted to examine multidimensional differences between the two groups, shedding light on the divergent outcomes of gene therapy and cochlear implants for patients with congenital deafness.

Conditions

Timeline

Start date
2024-04-06
Primary completion
2025-10-03
Completion
2026-12-22
First posted
2024-02-01
Last updated
2025-09-04

Locations

6 sites across 1 country: China

Source: ClinicalTrials.gov record NCT06237790. Inclusion in this directory is not an endorsement.